| Farmakoekonomi ve psikiyatrideki önemi | Mesut ÇETİN, Feyza ARICIOĞLU | 1–4 |
| Theory of mind in schizophrenia and Asperger`s syndrome: Relationship with negative symptoms | Bora BASKAK, Halise Devrimci OZGUVEN, Kerim MUNİR, Ozgür ONER, Ferhunde OKTEM, Olmez SENAY | 5–13 |
| Clinical factors associated with relapse in male alcohol dependents during six-month follow-up | Ercan DALBUDAK, Cüneyt EVREN, Rabia ÇETİN, Mine DURKAYA | 14–22 |
| Serotonin 5-HT1DB gene’s interaction with key brain regions in obsessive-compulsive disorder | Osman MERMİ, Murad ATMACA, Mustafa KOÇ, Sevda KORKMAZ, Ebru ONALAN, Hanefi YİLDİRİM, Sinan OZLER, Hüseyin YUCE, Bilge KARA | 23–28 |
| A comparison of reboxetine and amitryptilline in the treatment of fibromyalgia syndrome with co-morbid depressive symptoms: An open-label preliminary study | Numan KONUK, Sibel KİRAN, Ozgur ORTANCİL, Bora BOSTANCİ, Perihan SAPMAZ | 29–37 |
| The effects of methylphenidate on transcranial magnetic stimulation parameters in children with attention deficit hyperactivity disorder | İbrahim DURUKAN, Semai BEK, Mehmet Güney SENOL, Ozgur YORBİK, Erdal EROĞLU, M. Fatih OZDAĞ | 38–44 |
| Evaluation of autonomic nervous system function with tilt table testing in young adults with persistent developmental stuttering | Müzeyyen CİYİLTEPE, Celale OZCAN, Cemil CELİK, Basri AMASYALİ, Ali DORUK, Barbaros ÖZDEMİR | 45–49 |
| Prevalence of attention deficit hyperactivity disorder and comorbid disruptive behavior disorders among school age children in Trabzon | Murat TOPBAŞ, İsmail AK, Neyir GUL, S. Ebru Cengel KULTUR, Ahmet TİRYAKİ | 50–56 |
| Diagnosis and classification subtyping of depressive disorders: Comparison of three methods | Sibel ORSEL, Hasan KARADAĞ, Akfer Karaoğlan KAHİLOĞULLARI, Hkan TURKCAPAR | 57–65 |
| Erişkinlerde bipolar I bozukluk ve dikkat eksikliği hiperaktivite bozukluğu eştanısı: Bir ön çalışma | Osman ÖZDEL, Figen ATEŞCİ, Nalan K. OĞUZHANOĞLU, Halide D. TÜYSÜZOĞULLARO | 66–73 |
| İnme sonrası depresyon tedavisinde essitalopram |